Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.695
-0.015 (-0.55%)
Jun 8, 2026, 3:43 PM EDT - Market open
Altimmune Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 97.64 | 43.8 | 36.97 | 135.16 | 111.13 | 190.34 |
Short-Term Investments | 233.94 | 229.7 | 94.97 | 62.7 | 73.78 | - |
Cash & Short-Term Investments | 331.58 | 273.5 | 131.93 | 197.86 | 184.91 | 190.34 |
Cash Growth | 121.25% | 107.30% | -33.32% | 7.00% | -2.85% | -11.87% |
Accounts Receivable | 1.67 | 1.22 | 0.54 | 1.11 | 0.17 | 0.43 |
Other Receivables | - | 0.52 | 2.57 | 3.74 | 2.37 | 5.41 |
Total Trade Receivables | 1.67 | 1.74 | 3.12 | 4.85 | 2.54 | 5.84 |
Other Current Assets | 1.43 | 2.96 | 2.2 | 6.92 | 5.36 | 7.95 |
Total Current Assets | 334.68 | 278.19 | 137.25 | 209.63 | 192.81 | 204.13 |
Net Property, Plant & Equipment | 0.21 | 0.31 | 0.41 | 0.65 | 1.08 | 1.45 |
Other Intangible Assets | - | - | - | - | 12.42 | 12.42 |
Other Long-Term Assets | 0.75 | 1.43 | 1.64 | 0.36 | 0.62 | 0.87 |
Total Assets | 335.63 | 279.93 | 139.31 | 210.64 | 206.93 | 218.87 |
Accounts Payable | 1.53 | 2.72 | 0.21 | 2.07 | 4.8 | 2.03 |
Accrued Expenses | 9.79 | 12.28 | 10.26 | 10.07 | 12.25 | 10.15 |
Other Current Liabilities | - | - | - | - | - | 6.09 |
Total Current Liabilities | 11.32 | 15 | 10.47 | 12.14 | 17.05 | 18.28 |
Long-Term Debt | 34.51 | 34.29 | - | - | - | - |
Other Long-Term Liabilities | 5.82 | 5.75 | 5.33 | 4.4 | 4.58 | 1.45 |
Total Long-Term Liabilities | 40.32 | 40.04 | 5.33 | 4.4 | 4.58 | 1.45 |
Total Liabilities | 51.64 | 55.04 | 15.8 | 16.54 | 21.64 | 19.73 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
Additional Paid-in Capital | 961.24 | 879.29 | 689.86 | 665.43 | 568.4 | 497.34 |
Accumulated Other Comprehensive Income | -5.22 | -4.93 | -4.97 | -5 | -5.23 | -5.04 |
Retained Earnings | -672.05 | -649.48 | -561.39 | -466.33 | -377.88 | -293.17 |
Shareholders' Equity | 283.99 | 224.89 | 123.51 | 194.1 | 185.29 | 199.14 |
Total Liabilities & Equity | 335.63 | 279.93 | 139.31 | 210.64 | 206.93 | 218.87 |
Total Debt | 34.51 | 34.29 | 0 | 0 | 0 | 0 |
Net Cash (Debt) | 297.08 | 239.21 | 131.93 | 197.86 | 184.91 | 190.34 |
Net Cash Growth | 24.19% | 81.31% | -33.32% | 7.00% | -2.85% | -11.87% |
Net Cash Per Share | 3.00 | 2.71 | 1.86 | 3.72 | 3.94 | 4.61 |
Book Value | 283.99 | 224.89 | 123.51 | 194.1 | 185.29 | 199.14 |
Book Value Per Share | 2.87 | 2.55 | 1.74 | 3.65 | 3.95 | 4.82 |
Tangible Book Value | 283.99 | 224.89 | 123.51 | 194.1 | 172.87 | 186.72 |
Tangible Book Value Per Share | 2.87 | 2.55 | 1.74 | 3.65 | 3.68 | 4.52 |